SPY436.49-6.15 -1.39%
DIA345.05-3.56 -1.02%
IXIC14,656.80-313.17 -2.09%

BRIEF-Beigene Says U.S. FDA Grants Brukinsa (Zanubrutinib) Approval In Waldenström's Macroglobulinemia

reuters.com · 09/01/2021 21:42
BRIEF-Beigene Says U.S. FDA Grants Brukinsa (Zanubrutinib) Approval In Waldenström's Macroglobulinemia

- Beigene Ltd BGNE:

  • U.S. FDA GRANTS BRUKINSA® (ZANUBRUTINIB) APPROVAL IN WALDENSTRÖM'S MACROGLOBULINEMIA

Further company coverage: BGNE


((Reuters.Briefs@thomsonreuters.com;))